Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS)

About the company

Marinus Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the identification and development of neuropsychiatric therapeutics. Its clinical stage drug product candidate, ganaxolone, is a positive allosteric modulator being developed in three different dose forms: intravenous, capsule, and liquid. The company was founded by Geoffrey E. Chaiken, Harry H. Penner Jr., Vincent A. Pieribone and Kenneth R. Shaw on August 14, 2003 and is headquartered in Radnor, PA.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

40

$0.00M

Total Revenue

40

Employees

$168.21M

Market Capitalization

-2.50

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

Operating Margin (in %)

Total operating margin

Net Margin (in %)

Total net margin

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 11671.80 1376.00 4.98 18.40 43.06
Catalent, Inc. CTLT 10932.13 2872.00 5.49 104.81 3.63
Perrigo Co. Plc PRGO 7632.27 4837.00 1.31 52.07 3.02
Bausch Health Cos., Inc. BHC 6456.37 8597.00 9.01 -3.41 -21.96
Jazz Pharmaceuticals Plc JAZZ 6247.77 2188.00 2.16 22.84 12.81
United Therapeutics Corp. UTHR 5188.38 1443.00 1.80 10.01 36.59
MyoKardia, Inc. MYOK 4316.64 34.00 12.55 -13.92 -201.73
Axsome Therapeutics, Inc. AXSM 2672.60 None 18.14 -29.71 None
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
Pacira Biosciences, Inc. PCRX 2231.88 435.00 5.98 -5314.00 -0.02
SAGE Therapeutics, Inc. SAGE 2162.16 9.00 2.54 -3.34 -413.06
Corcept Therapeutics, Inc. CORT 2084.98 335.00 4.79 19.64 31.64
Revolution Medicines, Inc. RVMD 1920.45 48.00 4.98 -27.12 -146.29
Prestige Consumer Healthcare, Inc. PBH 1881.39 963.00 1.58 13.27 14.77
Madrigal Pharmaceuticals, Inc. MDGL 1683.75 0.00 4.49 -16.48 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1620.24 440.00 -22.93 19.11 19.14
Innoviva, Inc. INVA 1574.09 285.00 3.72 8.15 66.41
Intercept Pharmaceuticals, Inc. ICPT 1476.16 272.00 -43.93 -4.30 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Zogenix, Inc. ZGNX 1308.15 5.00 3.57 -3.08 -241.62
Supernus Pharmaceuticals, Inc. SUPN 1254.96 402.00 1.99 10.76 28.90
Theravance Biopharma, Inc. TBPH 1196.43 88.00 -8.40 -4.85 -280.80
Revance Therapeutics, Inc. RVNC 1181.11 0.00 4.66 -6.33 41.82
Amphastar Pharmaceuticals, Inc. AMPH 1088.78 327.00 2.72 21.37 15.90
Endo International Plc ENDP 800.28 3014.00 -1.09 -2.85 -9.09
BellRing Brands, Inc. BRBR 764.79 954.00 -0.41 5.80 13.98
Eagle Pharmaceuticals, Inc. EGRX 684.60 192.00 3.68 271.67 1.29
Aerie Pharmaceuticals, Inc. AERI 678.96 79.00 5.39 -3.35 -252.92
Assembly Biosciences, Inc. ASMB 676.28 16.00 3.03 -6.80 -601.75
Collegium Pharmaceutical, Inc. COLL 590.58 299.00 4.23 -45.71 -4.21
Anika Therapeutics, Inc. ANIK 539.98 125.00 1.87 19.48 22.73
Catalyst Pharmaceuticals, Inc. CPRX 487.92 119.00 4.75 11.12 36.09
Intersect ENT, Inc. XENT 411.20 102.00 3.88 -8.24 -48.61
BioDelivery Sciences International, Inc. BDSI 404.80 130.00 5.79 -55.00 -5.01
ANI Pharmaceuticals, Inc. ANIP 391.32 203.00 2.00 -250.85 -0.67
MEI Pharma, Inc. MEIP 354.41 5.00 6.10 -9.09 -539.48
Albireo Pharma, Inc. ALBO 343.07 11.00 3.49 -4.49 -730.55
Mallinckrodt Plc MNK 233.52 3037.00 0.12 -0.19 -39.56
Marinus Pharmaceuticals, Inc. MRNS 168.21 0.00 6.51 -2.50 None
Agile Therapeutics, Inc. AGRX 165.79 None 2.70 -8.03 None
Zynerba Pharmaceuticals, Inc. ZYNE 144.90 0.00 2.38 -4.04 -699.94
Cerecor, Inc. CERC 117.76 7.00 7.53 -5.22 -429.22
Ampio Pharmaceuticals, Inc. AMPE 97.81 1.00 68.40 -5.26 None
AcelRx Pharmaceuticals, Inc. ACRX 94.40 2.00 -1.74 -1.69 -644.25
Evoke Pharma, Inc. EVOK 84.96 None 29.50 -12.64 None
Adamas Pharmaceuticals, Inc. ADMS 70.28 57.00 -4.48 -0.76 -160.44
CTI BioPharma Corp. CTIC 67.85 3.00 3.03 -1.64 -111.83
Aclaris Therapeutics, Inc. ACRS 67.65 4.00 1.19 -0.49 None
Oramed Pharmaceuticals, Inc. ORMP 62.64 3.00 5.04 -4.90 -464.15
Cassava Sciences, Inc. SAVA 56.81 41.00 2.99 -12.46 76.71
Cumberland Pharmaceuticals, Inc. CPIX 49.95 47.00 1.02 -11.10 -9.59
SCYNEXIS, Inc. SCYX 49.93 0.00 10.49 -1.29 -30.84
Natural Alternatives International, Inc. NAII 48.37 114.00 0.66 -12.80 -3.19
IsoRay, Inc. ISR 37.77 9.00 7.05 -11.27 -36.08
Lipocine, Inc. LPCN 36.90 0.00 8.79 -2.46 None
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 34.50 65.00 -2.65 -1.97 -26.74
PLx Pharma, Inc. PLXP 27.99 0.00 -2.68 -2.96 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 19.61 3.00 2.44 -1.66 -264.21
Regulus Therapeutics, Inc. RGLS 14.91 0.00 1.31 -0.70 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.60 8.00 0.67 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.90 None 1.40 -0.25 None
VIVUS, Inc. VVUS 8.91 73.00 -0.20 -0.30 -39.28
Sonoma Pharmaceuticals, Inc. SNOA 6.93 19.00 1.10 -2.22 -25.58
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Hepion Pharmaceuticals, Inc. HEPA 5.42 None 1.69 -0.46 None
Tonix Pharmaceuticals Holding Corp. TNXP 4.36 None 1.09 -0.09 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Marinus Pharmaceuticals Provides Pipeline Update

1d ago, source: YAHOO!

Marinus Pharmaceuticals, Inc. (MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders, today provided a pipeline update in advance of ...

Marinus Pharmaceuticals to Host Pipeline Update Webinar

8d ago, source: YAHOO!

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare.

Marinus Pharmaceuticals (NASDAQ:MRNS) Receives Buy Rating from HC Wainwright

1d ago, source: modernreaders.com

HC Wainwright reaffirmed their buy rating on shares of Marinus Pharmaceuticals (NASDAQ:MRNS) in a report published on Tuesday ...

Marinus Pharmaceuticals Inc

6d ago, source: Bloomberg

Marinus Pharmaceuticals, Inc. manufactures medical products. The Company offers development and commercialization of medical drugs for the treatment of serious neurological and psychiatric ...

Marinus Pharmaceuticals to Present at SVB Leerink's CybeRx Series: 2nd Annual CNS Forum

9d ago, source: Stockhouse

Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders. Ganaxolone is a positive allosteric modulator of ...

19 Healthcare Stocks Moving In Friday's Pre-Market Session

13d ago, source: MSN

Biolase, Inc. (NASDAQ:BIOL) stock moved upwards by 7.10% to $0.53. • Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) stock rose 6.74% to $2.85. The most recent rating by Cantor Fitzgerald ...

Research Uncovers New Role Psychedelics Could Play in Therapy

7d ago, source: PR Newswire

Mydecine Innovations Group Inc. (OTC: MYCOF) (CSE: MYCO), Takeda Pharmaceutical Company Limited (NYSE: TAK), Teva Pharmaceutical Industries Limited (NYSE: TEVA), Marinus Pharmaceuticals ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.